electroCore, Inc. (ECOR): Cost of Revenue

Annual figures by period end, from SEC filings.

$4.24M
Year ended 2025-12-31
$4.79M
Trailing 12 months to 2026-06-30
+38.0%
3-year compound annual growth
+19.6%
5-year compound annual growth
2017-12-31: $518.5K2018-12-31: $578.7K2019-12-31: $1.16M2020-12-31: $1.74M2021-12-31: $1.39M2022-12-31: $1.62M2023-12-31: $2.80M2024-12-31: $3.79M2025-12-31: $4.24M$4.24M
2017-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$4.24M+12.1%2026-03-19, From 2025-01-01
2024-12-31$3.79M+35.0%2026-03-19, From 2024-01-01
2023-12-31$2.80M+73.5%2025-03-12, From 2023-01-01
2022-12-31$1.62M+16.7%2024-03-13, From 2022-01-01
2021-12-31$1.39M-20.3%2023-03-08, From 2021-01-01
2020-12-31$1.74M+50.2%2022-03-10, From 2020-01-01
2019-12-31$1.16M+99.9%2021-03-11, From 2019-01-01
2018-12-31$578.7K+11.6%2020-03-30, From 2018-01-01
2017-12-31$518.5Kn/a2019-03-28, From 2017-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
electroCore, Inc. (ECOR)2025-12-31$4.24M+12.1%
Stereotaxis, Inc. (STXS)2025-12-31$15.31M+24.2%
Precision Optics Corporation, Inc. (POCI)2026-06-30$26.10M+66.4%
Iridex Corp (IRIX)2026-01-03$33.45M+14.7%
QT Imaging Holdings, Inc. (QTI)2025-12-31$10.34M+361.9%
Electromed, Inc. (ELMD)2026-06-30$15.83M+12.9%
Hyperfine, Inc. (HYPR)2025-12-31$6.81M-2.7%
CapsoVision, Inc (CV)2025-12-31$6.38M+18.6%
Escalon Medical Corp (ESMC)2026-06-30$7.17M+9.7%

Compare ECOR, STXS, POCI, IRIX side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗